Our study further suggests that levels of IL8 in CSF higher than 135 ng/L, when measured in the acute phase before treatment in patients with GBS, may predict a more severe impairment at nadir and a higher probability of progression in the acute phase of the disease. This evidence concerns the gene CXCL8 and Guillain-Barre syndrome.